The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Current Developments in Salivary Diagnostics
Open accessAbstract
Salivary diagnostics is an emerging field that has progressed through several important developments in the past decade, including the publication of the human salivary proteome and the infusion of federal funds to integrate nanotechnologies and microfluidic engineering concepts into developing compact point-of-care devices for rapid analysis of this secretion. In this article, we discuss some of these developments and their relevance to the prognosis, diagnosis and management of periodontitis, as an oral target, and cardiovascular disease, as a systemic example for the potential of these biodiagnostics. Our findings suggest that several biomarkers are associated with distinct biological stages of these diseases and demonstrate promise as practical biomarkers in identifying and managing periodontal disease, and acute myocardial infarction. The majority of these studies have progressed through biomarker discovery, with the identified molecules requiring more robust clinical studies to enable substantive validation for disease diagnosis. It is predicted that with continued advances in this field the use of a combination of biomarkers in multiplex panels is likely to yield accurate screening tools for these diagnoses in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
The current state of serum biomarkers of hepatotoxicity
Ozer, J., Ratner, M., Shaw, M., Bailey, W., & Schomaker, S. (2008) · Toxicology · doi:10.1016/j.tox.2007.11.021 · Cited by 1,269
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Cited by
Point of Care Diagnostics: Status and Future
Gubala, V., Harris, L. F., Ricco, A. J., Tan, M. X., & Williams, D. E. (2012) · Analytical Chemistry · doi:10.1021/ac2030199 · Cited by 1,194
Diagnostic Potential of Saliva: Current State and Future Applications
Pfaffe, T., Cooper-White, J., Beyerlein, P., Kostner, K., & Punyadeera, C. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.153767 · Cited by 798
Malamud, D. (2011) · Dental Clinics of North America · doi:10.1016/j.cden.2010.08.004 · Cited by 489
Sorsa, T., Gursoy, U. K., Nwhator, S., Hernandez, M., Tervahartiala, T., Leppilahti, J., Gursoy, M., Könönen, E., Emingil, G., Pussinen, P. J., et al. (2016) · Periodontology 2000 · doi:10.1111/prd.12101 · Cited by 312
Role of Saliva and Salivary Diagnostics in the Advancement of Oral Health
Dawes, C., & Wong, D. T. W. (2019) · Journal of Dental Research · doi:10.1177/0022034518816961 · Cited by 218
Comparison of Biomarkers in Blood and Saliva in Healthy Adults
Williamson, S., Munro, C., Pickler, R., Grap, M. J., & Elswick, R. K. (2012) · Nursing Research and Practice · doi:10.1155/2012/246178 · Cited by 197
“Saliva has been widely analyzed as an indicator of oral health [6–8], and there has been recent interest in use of salivary components as surrogates for systemic biomarkers in blood [9].”
BackgroundGhallab, N. A. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.12.022 · Cited by 174
Belstrøm, D., Jersie-Christensen, R. R., Lyon, D., Damgaard, C., Jensen, L. J., Holmstrup, P., & Olsen, J. V. (2016) · PeerJ · doi:10.7717/peerj.2433 · Cited by 77
Recent trends in the development of diagnostic tools for diabetes mellitus using patient saliva
Viswanath, B., Choi, C. S., Lee, K., & Kim, S. (2017) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2017.01.011 · Cited by 75
Host‐microbe interactions: Profiles in the transcriptome, the proteome, and the metabolome
Nguyen, T., Sedghi, L., Ganther, S., Malone, E., Kamarajan, P., & Kapila, Y. L. (2020) · Periodontology 2000 · doi:10.1111/prd.12316 · Cited by 51
Goswami, N., Roma, P. G., De Boever, P., Clément, G., Hargens, A. R., Loeppky, J. A., Evans, J. M., Peter Stein, T., Blaber, A. P., Van Loon, J. J. W. A., et al. (2012) · Planetary and Space Science · doi:10.1016/j.pss.2012.07.030 · Cited by 49
Hong, W., & Lee, W. G. (2020) · The Analyst · doi:10.1039/d0an01484b · Cited by 47
Metadata
- Authors
- Miller, C. S., Foley, J. D., Bailey, A. L., Campell, C. L., Humphries, R. L., Christodoulides, N., Floriano, P. N., Simmons, G., Bhagwandin, B., Jacobson, J. W., Redding, S. W., Ebersole, J. L., & McDevitt, J. T.
- Venue
- Biomarkers in Medicine
- Publisher
- Informa UK Limited
- Published
- 2010-02
- Volume
- 4
- Issue
- 1
- Pages
- 171-189
- ISSN
- 1752-0363 (ISSN-L)
- 1752-0371
- OpenAlex
- W2121991787
- Cited by
- 389
- References
- 105
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.